Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving AdaptHealth Corp. (AHCO)
AdaptHealth reported $132 million in adjusted EBITDA for Q2 2026. On a GAAP basis, the Company posted a loss of $0.99 per share. Levi & Korsinsky is investigating potential securities law violations on behalf of AHCO investors who lost money
NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- AdaptHealth Corp. (NASDAQ: AHCO) shareholders watched as much as 26% of their investment disappear after the Company's Q2 2026 results showed a GAAP loss of $0.99 per share -- against roughly $0.15 of profit expected. If you lost money on AHCO, you are encouraged to click here to submit your information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
AdaptHealth reported adjusted EBITDA of $132 million for Q2 2026. The GAAP bottom line told a different story: a $0.99 per-share loss, as the Company simultaneously reduced its full-year 2026 revenue and adjusted EBITDA outlook.
Shareholders who purchased AHCO and suffered losses may request a free case evaluation here or call (212) 363-7500.
Levi & Korsinsky, LLP -- Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered.
Frequently Asked Questions About the AHCO Investigation
Q: How much did AHCO stock drop? A: Shares fell as much as 26% after AdaptHealth reported a GAAP loss of $0.99 per share alongside $132 million of adjusted EBITDA and a $144.2 million goodwill impairment charge. Investors who purchased shares and suffered losses may be eligible to seek recovery.
Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether AdaptHealth Corp. made materially false or misleading statements regarding its full-year 2026 revenue and adjusted EBITDA outlook. Less than three months later, the Company reset 2026 revenue guidance to approximately $2.85 billion to $2.89 billion and the stock price declined sharply.
Q: Who is eligible to participate in the AHCO investigation? A: Investors who purchased AHCO stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: What do AHCO investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at jlevi@levikorsinsky.com or (212) 363-7500.
Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I already sold my AHCO shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought AHCO and sold at a loss may still participate in the investigation.
Q: What does it cost me to participate? A: There is no upfront cost. Securities investigations and any resulting actions are generally handled on a contingency basis -- no retainer and no out-of-pocket costs.
Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
Tel: (212) 363-7500
Fax: (212) 363-7171
Attorney Advertising. Prior results do not guarantee similar outcomes.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
